This product has been shown to be effective for the vaccination of healthy dogs six weeks of age or older against disease caused by canine coronavirus.
Dosage: Dogs, inject one 1 mL dose subcutaneously or intramuscularly using aseptic technique. All dogs over 12 weeks of age should initially receive one dose of Duramune Cv-K and a second dose 2 to 3 weeks later. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian is recommended. This product has not been tested in pregnant animals.
A recommended vaccination schedule should start at or about 6 weeks of age. The presence of maternal antibody is known to interfere with the development of active immunity. Puppies should be revaccinated every 2 to 3 weeks until they are at least 12 weeks of age.
Preservatives: Gentamicin, thimerosal and amphotericin B.